1473 / 1851
HD0607
FFS in PET2 NEG +/- Radiotherapy (N=195)
(interim analysis, presented at Lugano ICML 2015)
0,00
0,25
0,50
0,75
1,00
TOT 32/97 (33.0%)
NO RXT 4/98 (14.3%)
RXT 5/97 (5.2%)
Log Rank Test P = 0.053
0
2
3
4
5
1
HR* (95% CI)
P
1.00
0.38 (0.14-1.05)
0.063
90%
94%
85%
Consolidative RT
All patients (195)
NO RT
Gallamini et al, ICML (Lugano) 2015, abstract 118